Roy F Get more information . Chemaly, M.D., Andrew J. Ullmann, M.D., Susanne Stoelben, M.D., Marie Paule Richard, M.D.D., Christoph Groth, M.D., Hermann Einsele, M.D., Margarida Silverman, M.D., Kathleen M. Mullane, M.D., Janice Brown, M.D., Horst Nowak, Ph.D.Sc., Hans P. Stobernack, D.V.M., Peter Lischka, Ph.D., Holger Zimmermann, Ph.D.D., Richard E. Champlin, M.D., and Gerhard Ehninger, M.D. For the AIC246 Study Team: Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation Cytomegalovirus disease that results from CMV replication through reactivation or new infections is a serious, potentially life-threatening condition in immunocompromised patients.
Scott Fleming, senior vice president of marketing, MicroDose, added By merging our innovative inhaler technology platform with 3M’s confirmed leadership in health care products and solid brand, we shall create a dynamic partnership providing unique inhalation product solutions for an expanded market. MicroDose and 3M presently would like business alliances with pharmaceutical and biotechnology companies thinking about the pulmonary delivery of their molecules.. 3M and MicroDose Systems Inc. Group to bring advanced electronic dry powder inhaler to advertise up 3M and MicroDose Systems Inc., a held drug delivery company located in Monmouth Junction privately, N.J., announced today that the two companies have entered into an exclusive co-development and joint marketing agreement.